Previous 10 | Next 10 |
WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care Diagnostics: A Clinician's View” U.S. survey, designed to understand physicians...
Early customers include GP offices and other community-based healthcare settings Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly half are undiagnosed 1 The LumiraDx HbA1c test is designed to address t...
LumiraDx Limited (LMDX) Q3 2022 Results Conference Call November 09, 2022 08:00 AM ET Company Participants Colleen McMillen - Vice President, Communications Ron Zwanziger - Chairman and CEO Dorian LeBlanc - Chief Financial Officer Conference Call Participan...
LumiraDx press release ( NASDAQ: LMDX ): Q3 Non-GAAP EPS of -$0.21 beats by $0.06 . Revenue of $42.22M (-61.3% Y/Y) beats by $7.41M . For further details see: LumiraDx Non-GAAP EPS of -$0.21 beats by $0.06, revenue of $42.22M beats by $7.41M
LONDON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced operational and financial results for the third quarter ended September 30, 2022. Q3 2022 revenue of $42.2 million compared to Q2 202...
LONDON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX ), a next-generation point of care (POC) diagnostics company, announced it will release its third quarter financial results on Wednesday, November 9 th , 2022. On the day of the release, LumiraDx wil...
LumiraDx ( NASDAQ: LMDX ) is down 15% in Thursday afternoon trading after its Q2 2022 results missed on the top and bottom lines . The adjusted net loss of $147.1M compared to consensus estimated loss of $63.5M. Revenue of $44.7M, a ~49% year-over-year dec...
LumiraDx Limited (LMDX) Q2 2022 Earnings Conference Call August 18, 2022, 8:00 AM ET Company Participants Colleen McMillen - Vice President, Communications Ron Zwanziger - Chairman and CEO Dorian LeBlanc - Chief Financial Officer Pooja Pathak - Chief Product ...
LumiraDx press release ( NASDAQ: LMDX ): Q2 GAAP EPS of -$0.58. Revenue of $44.7M (-48.7% Y/Y). cash balance at the end of the second quarter was $106 million For further details see: LumiraDx GAAP EPS of -$0.58, revenue of $44.7M
LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced operational and financial results for the second quarter ended June 30, 2022. Q2 2022 revenue of $44.7 million compared to Q1 2022 re...